Production of monoclonal antibodies using recombinant baculovirus displaying gp64-fusion proteins (Q40900707)

24 September 2017

Production of monoclonal antibodies using recombinant baculovirus displaying gp64-fusion proteins (English)

1 reference

24 September 2017

K M Lindley

1

1 reference

24 September 2017

J L Su

2

1 reference

24 September 2017

P K Hodges

3

1 reference

24 September 2017

G B Wisely

4

1 reference

24 September 2017

R K Bledsoe

5

1 reference

24 September 2017

J P Condreay

6

1 reference

24 September 2017

D A Winegar

7

1 reference

24 September 2017

J T Hutchins

8

1 reference

24 September 2017

T A Kost

9

1 reference

24 September 2017

1 February 2000

1 reference

Journal of Immunological Methods

24 September 2017

1 reference

24 September 2017

234

1 reference

24 September 2017

1-2

1 reference

24 September 2017

123-135

1 reference

Orphan nuclear receptors--new ligands and new possibilities.

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Generation of neutralizing antibody to the reverse transcriptase of human immunodeficiency virus type 1 by immunizing of mice with an infectious vaccinia virus recombinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Generation of monoclonal antibodies to human lymphocyte cell surface antigens using insect cells expressing recombinant proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Phage display as a rapid gene expression system: production of bioactive cytokine-phage and generation of neutralizing monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Chimeric potyvirus-like particles as vaccine carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Rapid development of affinity matured monoclonal antibodies using RIMMS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Gene gun delivered DNA-based immunizations mediate rapid production of murine monoclonal antibodies to the Flt-3 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

CpG motifs in bacterial DNA trigger direct B-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Infectious enveloped RNA virus antigenic chimeras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Baculovirus systems for the expression of human gene products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Cancer vaccines: novel approaches and new promise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Baculoviral display of the green fluorescent protein and rubella virus envelope proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

The LXRs: a new class of oxysterol receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Phage-display technology--finding a needle in a vast molecular haystack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Fluorescent microtiter screening assay for immunocytochemically reactive antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

DNA immunization targeting the skin: molecular control of adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Mechanism of neutralization of budded Autographa californica nuclear polyhedrosis virus by a monoclonal antibody: Inhibition of entry by adsorptive endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Neutralization of budded Autographa californica NPV by a monoclonal antibody: identification of the target antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

Inhibitory monoclonal antibody to human cytochrome P450 2B6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900133-7

10.1016/S0022-1759(99)00133-7

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference